Form 4: Bausch Health Director Acquires Shares

Frank D. Lee, a Director at Bausch Health Companies Inc., acquired 45,871 common shares through an RSU award.

Summary

• Frank D. Lee, a Director of Bausch Health Companies Inc. (BHC), acquired 45,871 common shares on May 22, 2026.
• This acquisition was part of an award of restricted share units (RSUs) granted to non-employee directors.
• The RSUs have a grant date value of $250,000 and vest on the day before the next Annual Meeting of Shareholders.
• Following this transaction, Mr. Lee beneficially owns 95,210 common shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, reflecting standard director compensation practices and a commitment to long-term alignment.

Positives

• Director acquisition of shares indicates confidence in the company's future.
• The RSU award is structured to align director compensation with long-term shareholder value, vesting prior to the next annual meeting.

Future Outlook

The RSUs granted to Mr. Lee vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, indicating a forward-looking incentive tied to continued service and company performance.

Industry Context

StockSavvy.ai notes that director share acquisitions, particularly through RSU awards, are common in the pharmaceutical and healthcare sectors as a means to attract and retain talent and align executive interests with shareholders.

Stakeholder Impact

• Shareholders: The acquisition by a director can be seen as a positive signal of confidence in the company's prospects.
• Employees: Standard compensation practice for non-employee directors, aligning their interests with the company.
• Management: Reinforces the alignment of director incentives with shareholder value.

Next Steps

• The RSUs will vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders.
• The RSUs will be settled in common shares of the Issuer.

Key Dates

Keywords

Bausch Health Companies, BHC, Form 4, SEC Filing, Insider Trading, Restricted Share Units, Director Compensation, Share Acquisition